What B12 treatments are available
Copper peptides (GHK-Cu) have been around in the bio-hacking and beauty space as injectables for a while now
Self-treating with unregulated or insufficiently evidenced products without first understanding the cause of hair loss may delay appropriate care and, in some cases, allow an underlying condition to progress
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Pain Management DSIP demonstrates analgesic properties by modulating central opioid receptors ( 6, 7 )